Insider Transactions in Q3 2023 at Palisade Bio, Inc. (PALI)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 27
2023
|
Donald Allen Williams Director |
BUY
Open market or private purchase
|
Indirect |
20,000
+50.0%
|
$0
$0.54 P/Share
|
|
Sep 27
2023
|
John David Finley CEO, CFO, Director |
BUY
Open market or private purchase
|
Direct |
15,000
+25.69%
|
$0
$0.54 P/Share
|
|
Sep 14
2023
|
Robert J. Trenschel Director |
SELL
Open market or private sale
|
Direct |
300
-100.0%
|
$0
$0.64 P/Share
|
|
Sep 13
2023
|
John David Finley CEO, CFO, Director |
BUY
Open market or private purchase
|
Direct |
15,000
+34.57%
|
$0
$0.66 P/Share
|
|
Sep 12
2023
|
John David Finley CEO, CFO, Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,792
-11.8%
|
$0
$0.66 P/Share
|
|
Sep 11
2023
|
John David Finley CEO, CFO, Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,558
+26.79%
|
-
|
|
Aug 11
2023
|
John David Finley CEO, CFO, Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,040
-9.75%
|
$0
$0.7 P/Share
|
|
Aug 06
2023
|
John David Finley CEO, CFO, Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,475
+23.91%
|
-
|
|
Jul 06
2023
|
John David Finley CEO, CFO, Director |
SELL
Payment of exercise price or tax liability
|
Direct |
389
-5.13%
|
$389
$1.76 P/Share
|
|
Jul 03
2023
|
John David Finley CEO, CFO, Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,309
+14.72%
|
-
|